PISCATAWAY, N.J. – Camber Pharmaceuticals announces the addition of mexiletine hydrochloride capsules, USP to its current portfolio.  

Mexiletine hydrochloride capsules, USP are for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening.

Mexiletine hydrochloride capsules, USP are available in 150, 200 and 250 mg strengths in 100 count bottles.